Addressing unmet patient needs in adults with chronic cough

Are you confident in the diagnosis and management of chronic cough as a unique disease entity? Are you up to date with the latest guidelines and available treatments?

Take this interactive eLearning module, accompanied by video content with expert respiratory physician Professor Kian Fan Chung, to learn about unmet patient needs, cough hypersensitivity, diagnostic and management algorithms, and to explore a chronic cough case study.

Course overview

Take this interactive EACCME^® accredited module and explore the unmet needs in the diagnosis and management of chronic cough in adults, featuring expert insight from Professor Kian Fan Chung.

Creation of this EACCME^® accredited module was funded by an educational grant from Merck Sharp & Dohme.

Faculty

Professor Kian Fan Chung

Professor Kian Fan Chung MD, DSc is Professor of Respiratory Medicine and Head of Experimental Studies Medicine at the National Heart and Lung Institute, Imperial College London, UK. He is a consultant respiratory physician at Royal Brompton and Harefield Hospitals, London. Professor Chung’s current interests are focused on the role of airway smooth muscle and the effects of oxidant stress on muscle function; the energetics of airway smooth muscle function; and the mechanisms underlying corticosteroid resistance. He has an interest in chronic cough, the cough hypersensitivity syndrome and in developing new treatments for the condition. Professor Chung is a senior investigator at the UK National Institute for Health Research and serves on the editorial boards of Respirology, Lancet Respiratory Medicine and the European Journal of Pharmacology.

Disclosures: Professor Chung reports receiving research grants through Imperial College from GSK on asthma and from Merck Sharp & Dohme on chronic cough. He has participated in advisory board meetings for AstraZeneca, GSK, Merck Sharp & Dohme, Nocion, Novartis, Reckitt-Benckiser, Roche, and Shionogi on asthma, chronic obstructive pulmonary disease (COPD) and chronic cough. He has undertaken speaking engagements for AstraZeneca, Merck Sharp & Dohme, Novartis, and Sanofi. He is on the Scientific Advisory Board of the Clean Breathing Institute, supported by Haleon. He obtained educational support from Merck Sharp & Dohme to his institution for the 12th London International Cough Symposium, held in July 2022.

Further information

Quick baseline questions will be asked at the start of the module to assess your background understanding. You will not be assessed on your responses to these questions.

Further questions will be asked at the end of each section. You must achieve a score of 70% or above in total to pass the course and be able to print your certificate. The certificate will be available on completion of the module.

On completion of this course, participants will be able to:

• identify the physical, psychological and social factors that impact the management of chronic cough
• describe the challenges associated with the diagnostic pathways of chronic cough
• state the ERS guideline recommendations for the treatment of chronic cough
• recall data for emerging treatment options for chronic cough